Utama › Serangan Jantung › Michigan
Kajian klinikal Serangan Jantung di Michigan
6 kajian untuk Serangan Jantung sedang mencari peserta di lokasi di Michigan.
Bandar di Michigan
Teks kajian rasmi (Bahasa Inggeris)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Paragon Health, Inc, Kalamazoo
- Michigan Kidney Consultants, PC, Pontiac
- St. Clair Nephrology Research, Roseville
- dan 1 lagi
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- Henry Ford Hospital, Detroit
- AA Medical Research Center, Flint
- Metro Health Univ of MI Health, Wyoming
Mengambil pesertaFasa 3
Umur 18 hingga 100 · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Henry Ford Health System, Detroit
- Healthy Heart Cardiology, Grand Rapids
- MyMichigan Medical Center Midland - Clinical Research Department, Midland
- dan 2 lagi
Mengambil pesertaFasa 3
Umur 50 hingga 105 · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT07136012AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
- Henry Ford Hospital, Detroit
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Jun 2026 · NCT06699056Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Henry Ford Health System, Detroit
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Mac 2026 · NCT04774159Focused Orticumab Research for Treating Inflammation in Coronary Arteries
- Abcentra Investigational Site, Midland
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Jan 2026 · NCT06927739Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.